Lycopene to track dietary compliance in healthy men
Official title: Plasma Lycopene Concentration as a Dietary Compliance Biomarker - a Pilot Study
Run by Erasmus Medical Center · NCT07117110 · Data updated 2026-11-12
This tests whether a single 40 mg dose of lycopene from a supplement or from tomato soup raises blood lycopene in healthy men so it can be used to track diet compliance.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | Men only |
| Enrollment | 10 (estimated) |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam) |
| Status | Recruiting |
| Started | July 11, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | August 12, 2025 |
| Trial ID | NCT07117110 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy men aged 18–75 without recent gastrointestinal disorders, not using medications or supplements that affect absorption, not smoking, and not following a restrictive diet are ideal candidates.
✕Probably not a fit
Women, children, people with a tomato allergy, those with recent GI disease, heavy smokers, or people on medications/supplements that alter fat or carotenoid absorption are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This crossover pilot enrolls ten healthy men aged 18–75 who each receive a single 40 mg oral dose of lycopene as a supplement tablet and, on a separate occasion, an equivalent amount in cooked tomato soup. Blood samples are taken one hour before and at 1, 3, 6, 12, 24, 48 and 72 hours after each intervention to measure plasma lycopene concentrations. Participants complete a food frequency questionnaire and keep a food diary to document habitual intake and intake during the intervention. The study examines whether the single-dose plasma response is consistent and large enough to serve as a practical compliance marker for dietary lycopene intake.
Why it matters
Potential benefit: If successful, this could provide a simple blood marker to confirm whether participants consumed lycopene-containing foods or supplements in nutrition studies.
How similar studies have gone: Previous research shows plasma lycopene increases after tomato consumption and supplementation, but using a single-dose plasma response as a compliance biomarker is a novel, pilot-level approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male; * Healthy; * 18-75 yrs old. Exclusion Criteria: * Allergic for tomatoes; * Any gastrointestinal disorder within 3 months prior to the intervention; * Recent medication or supplement use; * Recent substantial change in weight; * Adherence to a specific diet ( for example the Moorman-diet); * Using recreational drugs more than once a month; * Smoking and excessive alcohol consumption (\>10 standardized glasses a week). * Risk of a dependency situation with the researchers.
Where it's running
-
Erasmus MC
Rotterdam, Netherlands Recruiting
Study contacts
- Principal investigator: Lionne DF Venderbos — Erasmus Medical Center
- Study coordinator: Lionne DF Venderbos
- Email: l.venderbos@erasmusmc.nl
- Phone: 0031650001668
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.